Pastorova V E, Kovalev S V
Vopr Med Khim. 1976 Mar-Apr;22(2):240-5.
In experiments with rats, antithrombin III (a natural inhibitor of fibrinolysis) was shown to decrease the activation of the anticoagulation system either in prophylactic administration or during the development of thrombogenesis, caused by intravenous administration of tissue thromboplastin. The phenomenon led to the maintaining of the more high content of fibrinogen in blood of experimental animals, to the shortening of the thrombin time and to the increase in content of alpha2-macroglobulin and alpha1-antitrypsin (in-hibitors of fibrinolysis) as compard with control animals, administered with the only thrombolastin. Effect of antithrombin III depended on periods of administration of the prearation and on injection of tissue thromboplastin.
在对大鼠的实验中,抗凝血酶III(一种天然的纤维蛋白溶解抑制剂)被证明,无论是在预防性给药时,还是在因静脉注射组织凝血活酶而引发血栓形成的过程中,它都能降低抗凝系统的激活。这一现象导致实验动物血液中纤维蛋白原含量维持在较高水平,凝血酶时间缩短,并且与仅注射凝血活酶的对照动物相比,α2-巨球蛋白和α1-抗胰蛋白酶(纤维蛋白溶解抑制剂)的含量增加。抗凝血酶III的作用取决于制剂的给药时间以及组织凝血活酶的注射情况。